SPDR S&P Biotech ETF
424 hedge funds and large institutions have $5.82B invested in SPDR S&P Biotech ETF in 2019 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 134 increasing their positions, 137 reducing their positions, and 67 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
16.58% less ownership
Funds ownership: 144.73% → 128.15% (-17%)
33% less first-time investments, than exits
New positions opened: 45 | Existing positions closed: 67
54% less call options, than puts
Call options by funds: $849M | Put options by funds: $1.85B
Holders
424
Holding in Top 10
15
Calls
$849M
Puts
$1.85B
Top Buyers
| 1 | +$268M | |
| 2 | +$86.7M | |
| 3 | +$65.2M | |
| 4 |
DA
Duality Advisers
Miami,
Florida
|
+$45.8M |
| 5 |
Two Sigma Investments
New York
|
+$25M |
Top Sellers
| 1 | -$234M | |
| 2 | -$232M | |
| 3 | -$164M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$92.4M |
| 5 |
JPMorgan Chase & Co
New York
|
-$67.8M |